Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher P Filson

Showing results (41-50 of 121) with videos related to

Pageof 13
Sort By:
Cancer|February 5, 2021
Reply to What is a good medical choice?Christopher P Filson, Fangxin Hong, Niya Xiong, et al.
Clinical Genitourinary Cancer|March 2, 2019
Rise in Node-Positive Prostate Cancer Incidence in Context of Evolving Use and Extent of Pelvic LymphadenectomyMelissa A Taylor, Mehrdad Alemozaffar, Viraj A Master, et al.
Urologic Oncology|July 4, 2016
Determinants of radical cystectomy operative timeChristopher P Filson, Hung-Jui Tan, Karim Chamie, et al.
Cancer|October 29, 2020
Decision support for men with prostate cancer: Concordance between treatment choice and tumor riskChristopher P Filson, Fangxin Hong, Niya Xiong, et al.
Urologic Oncology|June 27, 2021
Palliative care use among bladder cancer patients treated with radical cystectomyNourhan Ismaeel, Dattatraya Patil, Mehrdad Alemozaffar, et al.
Cancer|June 17, 2021
Disparities in magnetic resonance imaging of the prostate for traditionally underserved patients with prostate cancerTimothy P Quinn, Martin G Sanda, David H Howard, et al.
Urology Practice|January 20, 2026
Real-World Utility of Cxbladder Triage for Patients with Microhematuria: A Matched Cohort StudyChristopher P Filson, Jeffrey M Slezak, Tiffany Q Luong, et al.
Open Access Journal of Urology|November 8, 2013
Role of biochemical markers in testicular cancer: diagnosis, staging, and surveillanceJaclyn C Milose, Christopher P Filson, Alon Z Weizer, et al.
Radiology. Imaging Cancer|March 29, 2021
In-Bore MRI-guided Prostate Biopsies: Retrospective Observational Study of Complementary Nontargeted Sampling of Normal-appearing Areas at Multiparametric MRIKareem K Elfatairy, Christopher P Filson, Martin G Sanda, et al.
Cancer|June 1, 2021
The value of new drugs for advanced prostate cancerDavid H Howard, Ruben G W Quek, Kathleen M Fox, et al.
Pageof 13

Showing results (41-50 of 121) with videos related to

Sort By:
Pageof 13
Cancer|February 5, 2021
Reply to What is a good medical choice?Christopher P Filson, Fangxin Hong, Niya Xiong, et al.
Clinical Genitourinary Cancer|March 2, 2019
Rise in Node-Positive Prostate Cancer Incidence in Context of Evolving Use and Extent of Pelvic LymphadenectomyMelissa A Taylor, Mehrdad Alemozaffar, Viraj A Master, et al.
Urologic Oncology|July 4, 2016
Determinants of radical cystectomy operative timeChristopher P Filson, Hung-Jui Tan, Karim Chamie, et al.
Cancer|October 29, 2020
Decision support for men with prostate cancer: Concordance between treatment choice and tumor riskChristopher P Filson, Fangxin Hong, Niya Xiong, et al.
Urologic Oncology|June 27, 2021
Palliative care use among bladder cancer patients treated with radical cystectomyNourhan Ismaeel, Dattatraya Patil, Mehrdad Alemozaffar, et al.
Cancer|June 17, 2021
Disparities in magnetic resonance imaging of the prostate for traditionally underserved patients with prostate cancerTimothy P Quinn, Martin G Sanda, David H Howard, et al.
Urology Practice|January 20, 2026
Real-World Utility of Cxbladder Triage for Patients with Microhematuria: A Matched Cohort StudyChristopher P Filson, Jeffrey M Slezak, Tiffany Q Luong, et al.
Open Access Journal of Urology|November 8, 2013
Role of biochemical markers in testicular cancer: diagnosis, staging, and surveillanceJaclyn C Milose, Christopher P Filson, Alon Z Weizer, et al.
Radiology. Imaging Cancer|March 29, 2021
In-Bore MRI-guided Prostate Biopsies: Retrospective Observational Study of Complementary Nontargeted Sampling of Normal-appearing Areas at Multiparametric MRIKareem K Elfatairy, Christopher P Filson, Martin G Sanda, et al.
Cancer|June 1, 2021
The value of new drugs for advanced prostate cancerDavid H Howard, Ruben G W Quek, Kathleen M Fox, et al.
Pageof 13